https://orcid.org/0000-0003-3439-9462
References
- Xia S, Ma L, Wang G, et al. In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients. Infect Drug Resist. 2022;15:1933–1944. doi:10.2147/IDR.S357077
- Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Disk Susceptibility Testing. 32nd ed. Vol. 42. Pennsylvania, USA: CLSI supplement M100; 2022.
- National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. National Centre For Disease Control, Directorate General Of Health Services Ministry Of Health & Family Welfare Government Of India. Version 1.0(2016); 1 - 644. Available from: https://ncdc.gov.in/WriteReadData/l892s/File622.pdf. Accessed May 11, 2022.
- Liu C, Bayer A, Cosgrove SE, et al, Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children, Clinical Infectious Diseases, Volume 52, Issue 3, 1 February 2011, Pages e18–e55, 10.1093/cid/ciq1464. Available from: http://cid.oxfordjournals.org/content/early/2011/01/04/cid.ciq146.full. Accessed May 11, 2022.